Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility  testing ) . dicloxacillin may be used to initiate therapy in suspected cases of resistant stap

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility  testing ) . dicloxacillin may be used to initiate therapy in suspected cases of resistant stap

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 272.5 mg (equivalent: flucloxacillin, qty 250 mg) - capsule, hard - excipient ingredients: povidone; brilliant blue fcf; magnesium stearate; sodium starch glycollate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; microcrystalline cellulose; gelatin - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - flucloxacillin sodium monohydrate, quantity: 2176 mg (equivalent: flucloxacillin, qty 2000 mg) - injection, powder for - excipient ingredients: - treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections including pneumonia, skin and skin structure and wound infections, infected burns and cellulitis.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

medra & pharma services limited - flucloxacillin sodium monohydrate 272mg equivalent to flucloxacillin 250 mg;  ;  ;  ;   - capsule - 250 mg - active: flucloxacillin sodium monohydrate 272mg equivalent to flucloxacillin 250 mg         excipient: magnesium stearate

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

medra & pharma services limited - flucloxacillin sodium monohydrate 544mg equivalent to flucloxacillin 500 mg;  ;  ;  ;   - capsule - 500 mg - active: flucloxacillin sodium monohydrate 544mg equivalent to flucloxacillin 500 mg         excipient: magnesium stearate

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

hospira nz ltd - flucloxacillin sodium monohydrate 262.1mg equivalent to 250 mg flucloxicillin;   - powder for injection - 250 mg - active: flucloxacillin sodium monohydrate 262.1mg equivalent to 250 mg flucloxicillin  

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

hospira nz ltd - flucloxacillin sodium monohydrate 524.2mg equivalent to 500 mg flucloxicillin.;   - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 524.2mg equivalent to 500 mg flucloxicillin.